INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

A review discusses NAD+ metabolism and the progress of NAD+-boosting therapies in cardiovascular diseases linked to sudden cardiac death.

This review examines the fundamentals of NAD+ homeostasis and its role as a co-substrate for proteins such as sirtuins, poly(ADP-ribose) polymerases, and cyclic ADP-ribose synthetases. It covers molecular physiology and recent advances in ischemic-reperfusion injury, heart failure, and arrhythmias associated with sudden cardiac death risk. Additionally, the authors summarize the progress of NAD+-boosting therapy in human cardiovascular diseases and discuss challenges for future studies.

Study type
Narrative review
Who was studied
Human and preclinical models of cardiovascular disease
What was measured
NAD+ homeostasis and therapy in cardiovascular diseases

THE PAPER

NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death.

Xu W, Li L, Zhang L. Front Physiol, 2020.

PubMed 32903597 ↗DOI 10.1161/01.cir.98.21.2334 ↗

Heart & arteriesHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.